Match tier
Likely match
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
N
Neil Dogra
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Graduate Student Researcher
1 pubs
Research Areas
Biography and Research Information
OverviewAI-generated summary
Neil Dogra's research focuses on investigating novel strategies to overcome resistance to immune checkpoint blockade (ICB) in melanoma. His work involves exploring the pharmacologic activation of ATF6 as a potential therapeutic approach. This research aims to identify new methods for improving cancer treatment outcomes in patients with melanoma.
Metrics
- Publications: 1
Selected Publications
-
Abstract 4036 Pharmacologic ATF6 Activation: A Novel Strategy to Overcome ICB Resistance in Melanoma (2026)
Collaboration Network
Top Collaborators
Sanjay Adhikary
1 shared publication
In database
- Abstract 4036 Pharmacologic ATF6 Activation: A Novel Strategy to Overcome ICB Resistance in Melanoma
Nathan Avaritt
1 shared publication
- Abstract 4036 Pharmacologic ATF6 Activation: A Novel Strategy to Overcome ICB Resistance in Melanoma
Katherine Bronson
1 shared publication
In database
- Abstract 4036 Pharmacologic ATF6 Activation: A Novel Strategy to Overcome ICB Resistance in Melanoma
Jake Edmondson
1 shared publication
- Abstract 4036 Pharmacologic ATF6 Activation: A Novel Strategy to Overcome ICB Resistance in Melanoma
Billie Heflin
1 shared publication
In database
- Abstract 4036 Pharmacologic ATF6 Activation: A Novel Strategy to Overcome ICB Resistance in Melanoma
Megan Reed
1 shared publication
- Abstract 4036 Pharmacologic ATF6 Activation: A Novel Strategy to Overcome ICB Resistance in Melanoma
Alan Tackett
1 shared publication
- Abstract 4036 Pharmacologic ATF6 Activation: A Novel Strategy to Overcome ICB Resistance in Melanoma
Similar Researchers
Based on overlapping research topics
Tracy L. Thurman
University of Arkansas for Medical Sciences
Disease Mechanisms Research
Immune Response and Inflammation
Receptor Mechanisms and Signaling
Edita M. Newton
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Receptor Mechanisms and Signaling
Gaven K. Smart
University of Arkansas at Fayetteville
Cancer Treatment and Pharmacology
Disease Mechanisms Research
Immune Response and Inflammation
Benjamin J. Lieblong
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Disease Mechanisms Research
Immune Response and Inflammation
Ahmad Mazen Safar
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Disease Mechanisms Research
Immune Response and Inflammation
Jim Angeles
University of Arkansas at Fayetteville
Cancer Treatment and Pharmacology
Disease Mechanisms Research
Receptor Mechanisms and Signaling